Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04244305
Other study ID # EGM-TXP-2016
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 1, 2016
Est. completion date May 1, 2020

Study information

Verified date January 2020
Source University Hospital A Coruña
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Lung Transplantation is usually the last option for patients with chronic respiratory conditions in the late stages of the disease. Pulmonary rehabilitation and, particularly, endurance training, is a cornerstone in the management of these patients both during the pre-operative as well as the post-operative period as it improves cardiopulmonary fitness, muscle mass, muscle strength, health-related quality of life and potentially, survival. However, very few studies have been published addressing which modality of training, intensity, frequency or duration of training provides the best possible results in these patients. Therefore, the objective of this study was to compare two training modalities (treadmill walking versus cycle-ergometry) on functional capacity, muscle strength and lung function.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 80
Est. completion date May 1, 2020
Est. primary completion date May 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing lung transplantation at the Thoracic Surgery Unit of the Hospital Clínico Universitario de A Coruña.

- Adults > 18 years.

- Ability to attend post-surgery exercise training for a minimum period of one month.

- Sign informed consent.

Exclusion Criteria:

- Torpid post-operative recovery with a prolonged stay at the Post-Anaesthesia Care Unit > 12 days.

- Diagnosed with intensive care unit acquired muscle weakness.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise Therapy
Endurance training in the form of treadmill/cycle-ergometry

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital A Coruña

Outcome

Type Measure Description Time frame Safety issue
Primary 6 Minute Walk Test Distance covered during the 6 Minute Walk Test performed according to the American Thoracic Guidelines. 1 month
Secondary 6 Minute Walk Test Distance covered with the 6 Minute Walk Test performed according to the American Thoracic Guidelines. 3 Months
Secondary Maximal isometric strength Isometrical maximal strength of the brachial biceps and quadriceps muscle of both dominant and non-dominant limbs. Maximal isometric strength will be assessed using a hand-held dynamometer (Lafayette Instrument, Model 01165) and will be presented in kilograms 1 and 3 months
Secondary Sit-to-stand Number of times the patient can stand up from a chair and sit back in 30 seconds 1 and 3 months
Secondary Forced Expiratory Volume 1st second (FEV1) Changes in Forced Expiratory Volume in the 1st second assessed during a forced spirometry test performed according to the international guidelines. 1 and 3 months
Secondary Incremental Symptom-Limited Test Incremental symptom-limited test performed on a cycle-ergometry with a 5-10W increase per minute up to maximal tolerance. Patient was monitorised during the test for both heart rate and oxygen saturation. 1 and 3 months
Secondary Maximal inspiratory and expiratory pressures Maximal inspiratory and expiratory pressures performed with the respiratory muscles 1 and 3 months
Secondary Forced Expiratory Capacity (FVC) Changes in forced expiratory capacity assessed during a forced spirometry test performed according to the international guidelines. 1 and 3 months
Secondary Peak Expiratory Flow (PEF) Changes in peak expiratory flow assessed during a forced spirometry test performed according to the international guidelines. 1 and 3 months
See also
  Status Clinical Trial Phase
Completed NCT02581111 - Naloxone for Optimizing Hypoxemia Of Lung Donors Phase 2/Phase 3
Recruiting NCT02177916 - Patient Education Study to Determine Knowledge Acquisition in Patients Preparing to Undergo Lung Transplantation N/A
Not yet recruiting NCT01394835 - Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients Phase 2
Not yet recruiting NCT01162148 - Pulmonary Rehabilitation and Inspiratory Muscle Training (IMT) for Patients Following Lung Transplantation N/A
Completed NCT01204970 - Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients N/A
Active, not recruiting NCT00980967 - Predictive Factors for Chronic Rejection in Lung Transplant Recipients: COLT Study N/A
Completed NCT00531921 - Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival N/A
Recruiting NCT00163696 - Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease N/A
Completed NCT00177684 - Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) Phase 3
Completed NCT00163891 - Comparison of Two Chest Physiotherapy Protocols in Lung Transplant Recipients N/A
Completed NCT03668483 - Relation Between Muscle Strength With Exercise Capacity and Dyspnea in LTx N/A
Not yet recruiting NCT02855372 - Impact of the Age Difference Between the Donor and Recipient on the Morbidity and Mortality After Lung Transplantation. Study on a National Multicenter Cohort (COLT) N/A
Completed NCT01211509 - Montelukast in Bronchiolitis Obliterans Syndrome Phase 4
Completed NCT01212406 - Vitamin D in Bronchiolitis Obliterans Syndrome Phase 4
Not yet recruiting NCT00808600 - Empowerment of Lung and Heart-lung Transplant Patients N/A
Completed NCT00553397 - Live Lung Donor Retrospective Study N/A
Completed NCT00402805 - Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy Phase 4
Terminated NCT00235651 - Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients Phase 3
Completed NCT00701922 - Surveillance Study of Viral Infections Following Lung Transplantation N/A
Active, not recruiting NCT02936505 - Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD. N/A